Aptevo Therapeutics Inc. Purchase Agreements
9 Contracts & Agreements
- Securities Purchase Agreement, dated August 1, 2023, between the Company and the purchasers party thereto (Filed With SEC on August 7, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on July 14, 2023)
- Amendment to Royalty Purchase Agreement dated June 7, 2022 (Filed With SEC on August 11, 2022)
- Purchase Agreement, dated February 16, 2022, by and between the Company and Lincoln Park (Filed With SEC on February 17, 2022)
- Royalty Purchase Agreement by and among Aptevo Therapeutics Inc. and Healthcare Royalty Partners IV, LP. dated as of March 30, 2021 (Filed With SEC on May 11, 2021)
- LLC Purchase Agreement by and among Aptevo Therapeutics Inc. and Medexus Pharma, Inc. dated February 28, 2020 (Filed With SEC on March 2, 2020)
- Amendment to LLC Purchase Agreement, dated as of August 31, 2017, by and among Aptevo BioTherapeutics LLC, Aptevo Therapeutics Inc., Venus Bio Therapeutics Sub LLC, and Saol... (Filed With SEC on August 9, 2019)
- Purchase Agreement between Aptevo Therapeutics Inc. and Lincoln Park Capital Fund, LLC, dated December 20, 2018 (Filed With SEC on December 24, 2018)
- LLC Purchase Agreement, dated as of August 31, 2017, by and among Aptevo BioTherapeutics LLC, Aptevo Therapeutics Inc., Venus Bio Therapeutics Sub LLC, and Saol International... (Filed With SEC on November 13, 2017)